| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/31/2002 | EP1226173A1 Single-chain antagonist polypeptides |
| 07/31/2002 | EP1226158A1 Process for preparing peptide intermediates |
| 07/31/2002 | EP1225918A2 Conjugates useful in the treatment of prostate cancer |
| 07/31/2002 | EP0833837B1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 07/31/2002 | CN1361789A Rapid dehydration of proteins |
| 07/30/2002 | US6426406 Forming polymorph; using lasers |
| 07/30/2002 | US6426402 Respiratory system disorders; rheumatic diseases |
| 07/30/2002 | US6426210 Storage of materials |
| 07/30/2002 | US6426190 Difference detection methods using matched multiple dyes |
| 07/30/2002 | US6426184 Making multimers such as dna or peptides in chemical reactor by solution-based photochemical reactions involving reagents generated in situ by irradiation |
| 07/30/2002 | CA2268433C Improved interferon polymer conjugates |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2072081C Polyhemoglobin stabilized by purine derivatives and glutathione |
| 07/30/2002 | CA2068279C Method of crystallizing aspartame |
| 07/30/2002 | CA2029201C Process for purifying b pertussis antigens |
| 07/25/2002 | WO2002057954A1 Method of constructing three dimensional structure of protein involving induced-fit and utilization thereof |
| 07/25/2002 | WO2002057792A2 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | WO2002057737A2 Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis |
| 07/25/2002 | WO2002057478A1 Methods and compositions for extracting proteins from cells |
| 07/25/2002 | WO2002057422A2 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | WO2002057313A2 Receptor-binding compounds and methods for identifying them |
| 07/25/2002 | WO2002057296A1 A method for refolding of proteins |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002056701A2 Gelling vegetable protein |
| 07/25/2002 | WO2002037094A3 Gel for electrophoresis |
| 07/25/2002 | WO2002037093A3 Gel trap for electrophoresis |
| 07/25/2002 | WO2001088160A3 Vectors for dna delivery |
| 07/25/2002 | WO2001000665A9 Inhibitors of memapsin 2 and use thereof |
| 07/25/2002 | WO2001000654A9 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 07/25/2002 | US20020099174 Filtration of plasma mixtures using cellulose-based filter aids |
| 07/25/2002 | US20020098595 Classification of prefrential proteins; obtain sample, insert into apparatus, analyze protein through mass spectroscopy |
| 07/25/2002 | US20020098583 Composition for use in the treatment of cell cycle defects, autoimmune diseases, aging, cancer, leukemia and psoriasis |
| 07/25/2002 | US20020098493 Drug-amino acids chimeric molecules |
| 07/25/2002 | US20020098277 Proteins are reduced with thiol redox proteins and further reacted with cystamine or oxidized glutathione to prevent reoxidation |
| 07/25/2002 | CA2447606A1 Ternary biomolecule/polymer/surface-based immobilization systems |
| 07/25/2002 | CA2434844A1 Methods and compositions for extracting proteins from cells |
| 07/25/2002 | CA2434472A1 Gelling vegetable protein |
| 07/25/2002 | CA2433354A1 Affinity selection-based screening of hydrophobic proteins |
| 07/25/2002 | CA2331676A1 Method for the expression, purification, and structure recovery and handling of hydrophobic proteins, polypeptides or peptides |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225180A2 Process for the production of virus-inactivated human gammaglobulin G |
| 07/24/2002 | EP1224455A1 Method for separating a chemical or biological compound in a mixture of similar compounds by diffusion in a medium such as a gel |
| 07/24/2002 | EP1224217A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 07/24/2002 | EP1224211A1 Process for the preparation of a dipeptide and intermediate product in such a process |
| 07/24/2002 | EP1224210A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 07/24/2002 | EP0977726B1 Process for esterification of amino acids and peptides |
| 07/24/2002 | EP0621285B1 Novel megakaryocyte potentiator |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1360563A Process for preparation of 3,3-dimethylbutanal |
| 07/23/2002 | US6423831 Isolation of neurotrophins from a mixture containing other proteins and neurotrophin variants using hydrophobic interaction chromatography |
| 07/23/2002 | US6423685 Method for increasing the serum half-life of a biologically active molecule |
| 07/23/2002 | US6423508 Polynucleotide sequences of human EDG-1c |
| 07/23/2002 | US6423313 Inhibition of tumor growth by blockade of the protein C system |
| 07/23/2002 | US6423271 Multilayer lamination device, exterior support, fluid pumps |
| 07/18/2002 | WO2002056024A2 Detection methods |
| 07/18/2002 | WO2002055992A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof |
| 07/18/2002 | WO2002055561A1 Method for surface display of proteins on genetic carriers |
| 07/18/2002 | WO2002055539A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | WO2002055538A2 Continuous separation method |
| 07/18/2002 | WO2002055537A1 Extractive purification of lipopeptide antibiotics |
| 07/18/2002 | WO2002055188A2 System and process for microfluidics-based automated chemistry |
| 07/18/2002 | WO2002031501B1 Methods for synthesizing reporter labeled beads |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001071359A3 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 07/18/2002 | US20020095028 Apparatus for continuous liquid phase adjustment and/or conjugation, purification and concentration of proteins |
| 07/18/2002 | US20020094544 Solid support for use as analytical tool in genetic analysis |
| 07/18/2002 | US20020094522 Evaluating effectiveness of viral therapy; obtain blood from virally infected human, incubate with delavirdine, nevirapine or efavirenz, monitor viral activity |
| 07/18/2002 | DE10065787C1 Verfahren zur Immobilisierung von Biomolekülen, funktionalisiertes Trägermaterial und seine Verwendung A process for the immobilization of biomolecules, functionalized support material and its use |
| 07/18/2002 | CA2433689A1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 07/18/2002 | CA2433688A1 Extractive purification of lipopeptide antibiotics |
| 07/17/2002 | EP1223534A1 Peptides representative of polypeptides of interest and antibodies directed thereagainst, and methods, systems and kits for generating and utilizing each |
| 07/17/2002 | EP1222603A2 Methods and compositions utilizing a branch and terminate algorithm for protein design |
| 07/17/2002 | EP1222459A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 07/17/2002 | EP1222275A2 Serum amyloid a isoform from colostrum |
| 07/17/2002 | EP1222152A1 A method for preparing and screening one or more compounds |
| 07/17/2002 | EP1169048A4 Hyaluronic acid mimics and methods related thereto |
| 07/17/2002 | EP0942922B1 Enzymatic degradation of carbohydrates in protein isolation methods |
| 07/17/2002 | CN1359469A Epitopes formed by non-covalent association of conjugates |
| 07/17/2002 | CN1359420A Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals |
| 07/17/2002 | CN1359390A Factor VII a inhibitors |
| 07/17/2002 | CN1359298A Novel indications of mannan-bindie lectin (MBL) in the treatment of immanocompromised individuals |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420340 Homogeneous preparation of protein, e.g. leptin, modified at the n-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 07/16/2002 | US6420169 Device for generating preferential nucleotide sequences; for use as tools drug design |
| 07/16/2002 | US6420148 Fixation of preferential polypeptides; obtain protein, incubate with preferential oxidase, evaluate fixed protein |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420123 Generation of preferential library on solid support; form solid support, incubate with chemical intermediates, couple intermediates, recover reaction product |
| 07/16/2002 | US6419919 Method for the augmentation of gene expression |
| 07/16/2002 | US6419918 Receptors of chemotactic peptide; leukemia therapy |
| 07/16/2002 | US6419883 Chemical synthesis using solvent microdroplets |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2097200C Protein tyrosine kinase |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2081869C Method for crystallization of .alpha.-l-aspartyl-l-phenylalanine methyl ester |
| 07/16/2002 | CA2069259C Method of crystallizing .alpha.-l-aspartyl-l-phenylalanine methyl ester |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |